Ask a business law question, get an answer ASAP!
Thousands of highly rated, verified business lawyers.
Click here to chat with a lawyer about your rights.

            A. Each board licensing healthcare providers shall establish by rule practice requirements based on applicable guidelines from the federal Centers for Disease Control and Prevention which will protect the public from the transmission of the hepatitis B virus or human immunodeficiency virus in the practice of a profession regulated by the appropriate board.

            B. The boards shall by rule, based on applicable guidelines from the federal Centers for Disease Control and Prevention, establish requirements and procedures for a licensee and a licensure applicant to report his status as a carrier of the hepatitis B virus or human immunodeficiency virus to the board and shall enforce such requirements and procedures.

            C. Each report of hepatitis B virus carrier status or human immunodeficiency virus carrier status filed by a licensee or licensure applicant in compliance with this Section and each record maintained and meeting held by the boards in the course of monitoring a licensee for compliance with the practice requirement established by Subsection A of this Section are confidential and exempt from the public records by La. Rev. Stat. 44:4(7), (9), and (11), except for the purpose of the investigation or prosecution of alleged violations of this Part by the boards.

            Acts 1991, No. 1009, §1; Acts 2018, No. 206, §3.